PODCAST

Neurology Minute

American Academy of Neurology

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Start Here
Careers in Neurology: Clinical Development
2d ago
Careers in Neurology: Clinical Development
Dr. Katrina Ignacio discusses the emerging subspecialty of clinical development.
Careers in Neurology: Clinical Development
2d ago
Careers in Neurology: Clinical Development
Dr. Katrina Ignacio discusses the emerging subspecialty of clinical development.
Corticosteroids in LGI1 Antibody Encephalitis
3d ago
Corticosteroids in LGI1 Antibody Encephalitis
Dr. Sarosh Irani discusses the use of corticosteroids as a first-line agent in the treatment of LGI1-antibody encephalitis.
NINDS Mission and Clinical Neurology with Walter Koroshetz
4d ago
NINDS Mission and Clinical Neurology with Walter Koroshetz
Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke, discusses the NINDS's mission and clinical neurology.
Neurosarcoidosis - Part 2
5d ago
Neurosarcoidosis - Part 2
Dr. Shuvro Roy discusses Neurosarcoidosis in part 2 of a 2 part series.
Neurosarcoidosis - Part 1
6d ago
Neurosarcoidosis - Part 1
Dr. Shuvro Roy discusses Neurosarcoidosis in part 1 of a 2 part series.
Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Jun 17 2022
Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Dr. Rae Bacharach discusses the Neurology Today article, "Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease". Show references:
Medicare Limitation of Aduhelm
Jun 16 2022
Medicare Limitation of Aduhelm
Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
EEG Patterns and Neurofilament Light After Cardiac Arrest
Jun 15 2022
EEG Patterns and Neurofilament Light After Cardiac Arrest
Dr. Linnéa Grindegård discusses the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest.
Adult Opsoclonus-Myoclonus Syndrome
Jun 14 2022
Adult Opsoclonus-Myoclonus Syndrome
Dr. Justin Abbatemarco discusses Adult Opsoclonus-Myoclonus Syndrome.
Pediatric Opsoclonus-Myoclonus Syndrome
Jun 13 2022
Pediatric Opsoclonus-Myoclonus Syndrome
Dr. Justin Abbatemarco discusses Pediatric Opsoclonus-Myoclonus Syndrome.
Early Detection of Parkinson’s Disease
Jun 10 2022
Early Detection of Parkinson’s Disease
Dr. Halley Alexander discusses the Neurology Today article, "Potential Parkinson's Risks Found Years Before Diagnosis". Show references:
Race-Ethnic Disparities in Stroke Thrombolysis
Jun 9 2022
Race-Ethnic Disparities in Stroke Thrombolysis
Dr. Scott Mendelson discusses racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke.  Show references:
A Review of L-arginine in MELAS
Jun 8 2022
A Review of L-arginine in MELAS
Dr. Gráinne Gorman discusses the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS).  Show references:
Post-Concussion Headache
Jun 7 2022
Post-Concussion Headache
Dr. Meeryo Choe discusses post-concussion headaches, from the May NeuroPanels webinar series. Show references:
Development of New or Enlarging MRI Lesions Rare in MOGAD
Jun 6 2022
Development of New or Enlarging MRI Lesions Rare in MOGAD
Dr. Stephanie Syc-Mazurek discusses her abstract, "Development of new or enlarging MRI lesions outside of attacks is rare in myelin oligodendrocyte glycoprotein antibody-associated disease". Show references:
Fentanyl Exposure
Jun 3 2022
Fentanyl Exposure
Dr. Derek Stitt discusses facts and the misinformation surrounding fentanyl exposure.
Pure Sleep Epilepsy in Patients With First Seizure
Jun 2 2022
Pure Sleep Epilepsy in Patients With First Seizure
Dr. Elaine Pang discusses the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults.  Show references:
Association of PD Symptoms with Quality of Life
Jun 1 2022
Association of PD Symptoms with Quality of Life
Dr. Meredith Bock discusses her paper about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson's disease.  Show references:
Continuum: Epilepsy
May 31 2022
Continuum: Epilepsy
Dr. Nathalie Jetté shares what she learned as the guest editor of the April 2022 Continuum issue on Epilepsy.
Acute Symptomatic Seizures Secondary to MOGAD
May 31 2022
Acute Symptomatic Seizures Secondary to MOGAD
Dr. Mayra Montalvo discusses her abstract, "Acute Symptomatic Seizures Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder" [MOGAD]. Show references: